Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)
about
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.Overview of CDK9 as a target in cancer research.Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
P2860
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@ast
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@en
type
label
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@ast
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@en
prefLabel
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@ast
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@en
P2093
P2860
P356
P1476
Reduced occurrence of tumor fl ...... nic lymphocytic leukemia (CLL)
@en
P2093
Amy J Johnson
Camille Doykin
Darlene Rozewski
Jeffrey A Jones
Joseph Flynn
Kami Maddocks
Kristie A Blum
Leslie A Andritsos
Michael H Cardone
P2860
P304
P356
10.1002/AJH.23946
P50
P577
2015-02-25T00:00:00Z